| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.50B | 34.17B | 31.78B | 26.12B | 19.40B | 16.54B |
| Gross Profit | 24.20B | 23.99B | 22.41B | 18.37B | 13.74B | 11.47B |
| EBITDA | 3.46B | 3.63B | 4.03B | 2.86B | 1.91B | -1.42B |
| Net Income | 1.95B | 1.76B | 2.19B | 1.63B | 923.75M | -2.39B |
Balance Sheet | ||||||
| Total Assets | 18.20B | 18.75B | 17.42B | 17.66B | 15.64B | 15.88B |
| Cash, Cash Equivalents and Short-Term Investments | 6.73B | 7.90B | 6.72B | 6.74B | 4.77B | 3.97B |
| Total Debt | 2.32B | 2.61B | 2.72B | 5.44B | 7.38B | 9.15B |
| Total Liabilities | 7.34B | 8.09B | 8.15B | 10.02B | 11.84B | 14.56B |
| Stockholders Equity | 10.86B | 10.66B | 9.27B | 7.64B | 3.80B | 1.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.80B | 2.74B | 1.99B | 799.58M | -1.71B |
| Operating Cash Flow | 0.00 | 3.08B | 3.93B | 2.85B | 1.70B | -651.76M |
| Investing Cash Flow | 0.00 | -1.59B | -2.41B | -968.00M | -923.11M | -1.25B |
| Financing Cash Flow | 0.00 | -828.96M | -3.56B | -71.85M | -167.19M | 2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥21.88B | 20.09 | ― | ― | ― | ― | |
69 Neutral | ¥58.33B | 52.27 | ― | 0.56% | 7.52% | 3.37% | |
66 Neutral | ¥49.53B | 39.57 | ― | 0.17% | 15.53% | -26.93% | |
66 Neutral | ¥43.74B | 18.76 | 17.09% | 1.37% | 4.01% | 3.32% | |
64 Neutral | ¥50.95B | 11.04 | ― | 2.41% | 6.49% | 4.27% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
46 Neutral | ¥43.98B | 76.37 | ― | 0.62% | 13.05% | -29.04% |